Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
4.91
Nov 17 • 3:59 PM ET Dollar change-0.38 Percentage change(-7.18%)
Aftermarket Close
4.91
Aftermarket • 7:30 PM ET Dollar change0.00 Percentage change(0.00%)
Index
-
Market Cap
60.37M
Enterprise Value
63.72M
Income
14.50M
Sales
60.08M
Book/sh
0.90
Cash/sh
1.03
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
150
IPO
Oct 02, 2020
P/E
-
Forward P/E
-
PEG
-
P/S
1.00
P/B
5.45
P/C
4.78
P/FCF
-
EV/EBITDA
25.49
EV/Sales
1.06
Quick Ratio
0.98
Current Ratio
2.25
Debt/Eq
0.09
LT Debt/Eq
0.06
Option/Short
Yes / Yes
EPS (ttm)
-0.40
EPS next Y
-0.31
EPS next Q
-0.10
EPS this Y
95.99%
EPS next Y
-169.57%
EPS next 5Y
-
EPS past 3/5Y
-13.51% -9.65%
Sales past 3/5Y
18.23% 17.24%
EPS Y/Y TTM
127.29%
Sales Y/Y TTM
1.59%
EPS Q/Q
-23.58%
Sales Q/Q
-1.29%
Insider Own
19.90%
Insider Trans
0.00%
Inst Own
43.16%
Inst Trans
-8.44%
ROA
21.13%
ROE
227.84%
ROIC
55.26%
Gross Margin
50.51%
Oper. Margin
-3.29%
Profit Margin
24.13%
SMA20
-10.73%
SMA50
-21.97%
SMA200
-30.10%
Trades
Shs Outstand
12.29M
Shs Float
9.85M
52W High
12.94 -62.06%
52W Low
4.30 14.19%
Volatility
10.51% 6.35%
ATR (14)
0.36
RSI (14)
36.14
Beta
1.05
Rel Volume
1.52
Avg Volume
73.66K
Volume
111,967
Perf Week
6.28%
Perf Month
-14.61%
Perf Quarter
-43.69%
Perf Half Y
-15.34%
Perf YTD
-57.78%
Perf Year
-50.20%
Perf 3Y
124.20%
Perf 5Y
-32.83%
Perf 10Y
-
Prev Close
5.29
Price
4.91
Change %
-7.18%
Consensus
Strong Buy
Avg. Price Target
$11.00
Implied Upside
+124.0%
Analysts3incl. previous ratings
Rating Distribution3 Buy · 0 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Apr 01, 2026Upgrade
LLake Street
Hold → Buy$10+103.7%
Mar 18, 2026Upgrade
BBTIG Research
Neutral → Buy$10+103.7%
Feb 24, 2021Initiated
SSVB Leerink
Outperform$20+307.3%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ELIZABETH G O'FARRELLDirectorNov 17 '26Proposed Sale5.2022,214115,535Nov 17 05:07 PM
STAAB THOMAS R IIOfficerMay 12 '26Proposed Sale5.758504,888May 12 01:12 PM
STAAB THOMAS R IIChief Financial OfficerMar 19 '26Option Exercise2.655,50014,575175,959Mar 19 04:45 PM
LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. Its product offers automation and customization options for astigmatism treatment planning and other steps of the refractive cataract surgery procedure. The company was founded by Scott Addyman, Randy W. Frey, and Ronald R. Krueger in 2004 and is headquartered in Orlando, FL.
PresidentMr. Nicholas T. Curtis
Chief Operating OfficerMr. Alan B. Connaughton
Interim CFO & Principal Financial Officer and SecretaryMr. Michael A. Rossi
Principal Accounting OfficerMs. Kendra W. Wong